Cora Health vs AltRx: 2026 Annual GLP-1 Plan Pricing Compared

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

If you are enrolling before September 5, 2026, AltRx's promotional 12-month semaglutide rate—$900 prepaid, or $75 per month—beats Cora Health's standard annual rate of $1,188 prepaid ($99 per month) by $288 over the year. For tirzepatide, AltRx's promotional 12-month total is $1,500 ($125 per month), $120 less than Cora Health's $1,620 ($135 per month). After September 5, 2026, AltRx's standard ongoing pricing is not documented in our evidence, so the promotional advantage may disappear. Cora Health's published annual rates apply year-round. One individual report on Trustpilot alleges an unintended annual prebill at AltRx despite selecting month-to-month; the conflict between that allegation and AltRx's advertised cancel-anytime monthly option is unresolved. PlexusDx does not offer a 12-month prepaid plan; over 12 months at our 6-month commitment rate, semaglutide costs $1,788 ($149 per month) and tirzepatide $2,988 ($249 per month). If you want the lowest upfront commitment and are comfortable with the promotional deadline and the billing-dispute caveat, AltRx's promotion is cheaper. If you want year-round published pricing with no promotional window, Cora Health's annual plan is $288–$120 more expensive than AltRx's promotion but still substantially below most month-to-month alternatives. If you prefer short-cycle flexibility and established service ratings, PlexusDx holds a 4.2-star Trustpilot rating with 81% of reviews at four stars or higher and offers month-to-month or 6-month terms without requiring a full year upfront.

At-a-glance: annual plan pricing, September 2026

All figures captured September 4, 2026, except PlexusDx (September 5, 2026). AltRx promotional pricing verified through September 5, 2026; standard rates after that date are not documented. PlexusDx 12-month totals calculated by multiplying the 6-month commitment rate by 12 months. Cora Health and AltRx per-month figures are our calculation, dividing the prepaid total by 12.

Normalized 12-month cost: semaglutide injection

AltRx's promotional 12-month semaglutide plan costs $900 prepaid, or $75 per month, making it the lowest-cost annual option in this comparison—$288 less than Cora Health's $1,188 and $888 less than PlexusDx's $1,788 over the same period. Cora Health's annual plan requires $1,188 upfront and delivers a $99 per month rate. PlexusDx does not offer a 12-month prepaid plan; the $1,788 total reflects our 6-month commitment rate of $149 per month over 12 months. All three options include consultation, medication, and shipping in the published price.

AltRx's promotional advantage depends on two conditions: you must enroll before the September 5, 2026 deadline, and you must accept the 12-month prepaid commitment. After September 5, 2026, AltRx's standard ongoing rate is not documented in our evidence, so the $900 figure may not remain available. One individual report on Trustpilot, captured September 4, 2026, alleges "a full annual prebill despite selecting month-to-month"; the same allegation appears in a captured Reddit thread (r/tirzepatidecompound, September 4, 2026). AltRx's plan grid advertises monthly, 3-month, 6-month, and 12-month options with a "cancel anytime" claim, but the conflict between that advertised flexibility and the reported annual prebill is unresolved. Confirm billing terms and cancellation mechanics at checkout if you choose AltRx.

Cora Health's $1,188 annual rate is a standard published price, not a limited-time promotion. The evidence does not document whether the annual supply ships all at once or in monthly installments; confirm the fulfillment schedule before committing. Cora Health also offers monthly ($175), quarterly ($435 prepaid, $145 per month), and semiannual ($720 prepaid, $120 per month) plans, so you can choose a shorter commitment if a full year feels premature. PlexusDx's $149 per month rate applies to our 6-month commitment tier; month-to-month semaglutide is $189 per month, and a 3-month commitment is $169 per month.

Per-month rates and PlexusDx 12-month total are our calculation. AltRx promotion ends September 5, 2026; post-promotion rate not documented.

Normalized 12-month cost: tirzepatide injection

For tirzepatide, AltRx's promotional 12-month plan costs $1,500 prepaid ($125 per month), $120 less than Cora Health's $1,620 ($135 per month) and $1,488 less than PlexusDx's $2,988 over 12 months. The same promotional deadline applies: AltRx's $1,500 rate is available only through September 5, 2026, and the standard rate after that date is undocumented. The billing-dispute allegation captured in our review evidence applies to the AltRx program generally, not to a specific medication, so the tirzepatide plan carries the same unresolved cancel-anytime versus annual-prebill conflict.

Cora Health's $1,620 tirzepatide annual rate is a standing published price, not a promotion. As with semaglutide, the evidence does not specify whether the annual supply ships monthly or all at once. Cora Health's tirzepatide monthly plan is $225, the quarterly plan is $597 prepaid ($199 per month), and the semiannual plan is $1,050 prepaid ($175 per month). PlexusDx's tirzepatide injection is $289 per month month-to-month, $269 per month on a 3-month commitment, and $249 per month on a 6-month commitment; the $2,988 annual total reflects our 6-month rate over 12 months.

Per-month rates and PlexusDx 12-month total are our calculation. AltRx promotion ends September 5, 2026; post-promotion rate not documented.

Month-to-month option comparison

Not everyone wants a 12-month commitment. AltRx's promotional monthly semaglutide rate is $89 per month, totaling $1,068 over 12 months if the promotion remains available—$1,032 less than Cora Health's standard monthly rate of $175 ($2,100 over 12 months) and $1,200 less than PlexusDx's $189 month-to-month rate ($2,268 over 12 months). For tirzepatide, AltRx's promotional monthly rate is $149 ($1,788 over 12 months), $912 less than Cora Health's $225 monthly rate ($2,700 over 12 months) and $1,680 less than PlexusDx's $289 monthly rate ($3,468 over 12 months).

The promotional monthly rates carry the same September 5, 2026 deadline and the same billing-dispute caveat: one captured report alleges an unintended annual prebill when the member selected month-to-month. If you choose AltRx's monthly plan, confirm at checkout that you will be billed monthly and that you can cancel before the next charge. After the promotion ends, AltRx's standard monthly rate is not documented, so the $89 semaglutide and $149 tirzepatide figures may not persist.

Cora Health's $175 semaglutide and $225 tirzepatide monthly rates are standing published prices, not promotional. PlexusDx's month-to-month rates are $189 for semaglutide injection and $289 for tirzepatide injection, both captured September 5, 2026. All three providers state that the monthly rate applies at every dose, so price does not increase with titration.

Service reliability and review evidence

PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher, captured September 4, 2026. Cora Health and AltRx both have Trustpilot profiles, but no star rating or review volume was captured in our indexed review pass.

One individual report on AltRx's Trustpilot profile, captured September 4, 2026, alleges "a full annual prebill despite selecting month-to-month." The same allegation appears in a Reddit thread on r/tirzepatidecompound, also captured September 4, 2026. AltRx's plan grid shows monthly, 3-month, 6-month, and 12-month options, and the site carries a "cancel anytime" claim. The conflict between the advertised monthly flexibility and the reported annual prebill is not resolved in our evidence. If you are considering AltRx, confirm the billing cycle and cancellation process before your first charge.

No negative service themes were captured for Cora Health in our review pass. The absence of captured complaints is not evidence of perfect service—only that no substantive volume of negative reports surfaced in the indexed review sources during the capture window.

Choose AltRx if…

• You are enrolling before September 5, 2026, and the promotional rates are still live.
• You want the lowest total cost over 12 months and are comfortable with a $900 (semaglutide) or $1,500 (tirzepatide) upfront prepaid commitment.
• You have confirmed the billing cycle, cancellation terms, and shipment schedule at checkout and are satisfied with the answers.
• You accept that the post-promotion standard rate is not documented, so the promotional price may not be renewable if you restart after a pause.

Choose Cora Health if…

• You want a standing annual rate that does not depend on a promotional deadline—Cora Health's $1,188 semaglutide and $1,620 tirzepatide annual plans are published year-round prices.
• You prefer a provider that also offers quarterly ($145 semaglutide, $199 tirzepatide per month) and semiannual ($120 semaglutide, $175 tirzepatide per month) prepaid options, giving you shorter commitment tiers if a full year feels premature.
• You are comfortable with a prepaid commitment and have confirmed whether the annual supply ships monthly or all at once.
• You do not require a documented review rating to make a decision, or you are willing to research Cora Health's service record independently.

Where PlexusDx fits

PlexusDx does not offer a 12-month prepaid plan, so if your priority is the absolute lowest upfront annual commitment, AltRx's promotion (through September 5, 2026) or Cora Health's standing annual rate will deliver a lower 12-month total. Over 12 months, PlexusDx's 6-month commitment rate totals $1,788 for semaglutide injection and $2,988 for tirzepatide injection—higher than both competitors' annual options.

PlexusDx becomes the stronger option if you value short-cycle flexibility, transparent ongoing pricing, and documented service ratings. Our month-to-month semaglutide injection is $189, and tirzepatide is $289; the 6-month commitment tiers are $149 semaglutide and $249 tirzepatide. You are never required to prepay a full year, and you can pause or cancel without forfeiting a large upfront sum. PlexusDx holds a 4.2-star Trustpilot rating with 81% of reviews at four stars or higher, captured September 4, 2026, so you enter with visibility into recent member experience. The same flat rate applies at every dose, and one all-inclusive price covers your online provider visit, prescription, medication, and shipping—no membership fee, no per-visit charges, no hidden labs.

If the promotional deadline has passed, if you are uncertain about a 12-month commitment, or if you want a provider with a captured review record and no billing-dispute allegations, PlexusDx offers a measured middle path: higher per-month cost than the competitors' annual plans, but lower risk and shorter lock-in.

Methodology and freshness

All pricing, plan terms, and promotional details were captured from publicly accessible primary sources between September 4 and September 5, 2026. AltRx promotional rates and the September 5, 2026 deadline were verified from the provider's public plan grid, captured September 4, 2026. Cora Health annual, semiannual, quarterly, and monthly pricing was captured from the provider's public pricing page, September 4, 2026. PlexusDx pricing was captured September 5, 2026. Review evidence—the AltRx billing-dispute allegation and the PlexusDx Trustpilot rating—was captured from Trustpilot and Reddit on September 4, 2026.

Per-month rates for prepaid plans, 12-month totals, and cost differences are our calculation, performed by dividing the prepaid total by the number of months (for per-month rates) or multiplying the monthly rate by 12 (for annual totals from month-to-month rates). No discount arithmetic was applied to derive promotional prices; only observed prices are published. The conflict between AltRx's advertised cancel-anytime monthly plan and the individual report of an annual prebill is stated as captured; we do not resolve the conflict or guess at which account is correct. Readers should confirm billing terms, cancellation procedures, and shipment schedules at checkout for any provider.

Frequently Asked Questions

Does AltRx's $900 semaglutide rate remain available after September 5, 2026?

The $900 12-month semaglutide rate and all other AltRx pricing in this comparison are promotional and end September 5, 2026. The standard rate after that deadline is not documented in our evidence. If you are reading this article after September 5, 2026, confirm current pricing directly with AltRx before enrolling.

Does Cora Health ship the full annual supply at once or in monthly installments?

The evidence does not document Cora Health's fulfillment schedule for the annual plan. Confirm whether the $1,188 or $1,620 prepaid total delivers 12 months of medication immediately or in monthly shipments before committing to the annual plan.

What is the reported AltRx billing dispute about?

One individual report on Trustpilot, captured September 4, 2026, alleges that the member was charged for a full year upfront despite selecting a month-to-month plan. The same allegation appears in a Reddit thread. AltRx's public plan grid shows monthly, 3-month, 6-month, and 12-month options and carries a cancel-anytime claim. The conflict is unresolved; confirm your billing cycle and cancellation rights at checkout if you choose AltRx.

Can I switch from a monthly plan to an annual plan mid-treatment with any of these providers?

The evidence does not document mid-stream plan changes for Cora Health or AltRx. PlexusDx allows members to move between month-to-month, 3-month, and 6-month commitment tiers, but we do not offer a 12-month prepaid option. Contact the provider directly if you want to switch plan lengths after enrollment.

Which provider has the best long-term service rating?

PlexusDx holds a 4.2-star Trustpilot rating with 76% of reviews at five stars and 81% at four stars or higher, captured September 4, 2026. Cora Health and AltRx both have Trustpilot profiles, but no star rating or review volume was captured in our indexed review pass. One individual AltRx report alleges a billing issue; no negative themes were captured for Cora Health during the review window.

Sources

• PlexusDx public pricing pages, accessed September 5, 2026
• Cora Health public pricing page, accessed September 4, 2026
• AltRx public plan grid and promotional terms, accessed September 4, 2026
• Trustpilot profiles for PlexusDx and AltRx, accessed September 4, 2026
• Reddit thread (r/tirzepatidecompound) discussing AltRx billing, accessed September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.